Long term intrinsic cycling in human life course antibody responses to influenza A(H3N2): an observational and modelling study

  1. Bingyi Yang  Is a corresponding author
  2. Bernardo García-Carreras
  3. Justin Lessler
  4. Jonathan M Read
  5. Huachen Zhu
  6. C Jessica E Metcalf
  7. James A Hay
  8. Kin O Kwok
  9. Ruiyun Shen
  10. Chao Q Jiang
  11. Yi Guan
  12. Steven Riley  Is a corresponding author
  13. Derek A Cummings  Is a corresponding author
  1. University of Hong Kong, Hong Kong
  2. University of Florida, United States
  3. University of North Carolina at Chapel Hill, United States
  4. Lancaster University, United Kingdom
  5. Princeton University, United States
  6. Harvard TH Chan School of Public Health, United States
  7. Chinese University of Hong Kong, China
  8. Guangzhou Number 12 People's Hospital, China
  9. Imperial College London, United Kingdom

Abstract

Background: Over a life-course, human adaptive immunity to antigenically mutable pathogens exhibits competitive and facilitative interactions. We hypothesize that such interactions may lead to cyclic dynamics in immune responses over a lifetime.

Methods: To investigate the cyclic behavior, we analyzed hemagglutination inhibition titers against 21 historical influenza A(H3N2) strains spanning 47 years from a cohort in Guangzhou, China and applied Fourier spectrum analysis. To investigate possible biological mechanisms, we simulated individual antibody profiles encompassing known feedbacks and interactions due to generally recognized immunological mechanisms.

Results: We demonstrated a long-term periodicity (about 24 years) in individual antibody responses. The reported cycles were robust to analytic and sampling approaches. Simulations suggested that individual-level cross-reaction between antigenically similar strains likely explain the reported cycle. We showed that the reported cycles are predictable at both individual and birth-cohort level and that cohorts show a diversity of phases of these cycles. Phase of cycle was associated with the risk of seroconversion to circulating strains, after accounting for age and pre-existing titers of the circulating strains.

Conclusions: Our findings reveal the existence of long-term periodicities in individual antibody responses to A(H3N2). We hypothesize that these cycles are driven by pre-existing antibody responses blunting responses to antigenically similar pathogens (by preventing infection and/or robust antibody responses upon infection), leading to reductions in antigen specific responses over time until individual's increasing risk leads to an infection with an antigenically distant enough virus to generate a robust immune response. These findings could help disentangle cohort-effects from individual-level exposure histories, improve our understanding of observed heterogeneous antibody responses to immunizations, and inform targeted vaccine strategy.

Funding: This study was supported by grants from the NIH R56AG048075 (D.A.T.C., J.L.), NIH R01AI114703 (D.A.T.C., B.Y.), the Wellcome Trust 200861/Z/16/Z (S.R.) and 200187/Z/15/Z (S.R.). This work was also supported by research grants from Guangdong Government HZQB-KCZYZ-2021014 and 2019B121205009 (Y.G. and H.Z.). D.A.T.C., J.M.R. and S.R. acknowledge support from the National Institutes of Health Fogarty Institute (R01TW0008246). J.M.R. acknowledges support from the Medical Research Council (MR/S004793/1) and the Engineering and Physical Sciences Research Council (EP/N014499/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for Figures 1 to 4.

Article and author information

Author details

  1. Bingyi Yang

    Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong
    For correspondence
    byyang@connect.hku.hk
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0811-8332
  2. Bernardo García-Carreras

    Department of Biology, University of Florida, Gainesville, United States
    Competing interests
    Bernardo García-Carreras, BGC received financial research support through his institution from Merck for unrelated work.
  3. Justin Lessler

    UNC Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, United States
    Competing interests
    Justin Lessler, JL receives research support from CDC and NIH-NIGMS for for unrelated work..
  4. Jonathan M Read

    Centre for Health Informatics Computing and Statistics, Lancaster University, Lancaster, United Kingdom
    Competing interests
    No competing interests declared.
  5. Huachen Zhu

    Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong
    Competing interests
    No competing interests declared.
  6. C Jessica E Metcalf

    Department of Ecology and Evolutionary Biology, Princeton University, Princeton, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3166-7521
  7. James A Hay

    Center for Communicable Disease Dynamics, Harvard TH Chan School of Public Health, Boston, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1998-1844
  8. Kin O Kwok

    The Jockey Club School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China
    Competing interests
    No competing interests declared.
  9. Ruiyun Shen

    Guangzhou Number 12 People's Hospital, Guangzhou, China
    Competing interests
    No competing interests declared.
  10. Chao Q Jiang

    Guangzhou Number 12 People's Hospital, Guangzhou, China
    Competing interests
    No competing interests declared.
  11. Yi Guan

    Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong
    Competing interests
    No competing interests declared.
  12. Steven Riley

    Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom
    For correspondence
    s.riley@imperial.ac.uk
    Competing interests
    Steven Riley, SR receives grants from Wellcome Trust..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7904-4804
  13. Derek A Cummings

    Department of Biology, University of Florida, Gainesville, United States
    For correspondence
    datc@ufl.edu
    Competing interests
    Derek A Cummings, DATC received financial research support through his institution from Merck for unrelated work.

Funding

National Institute on Aging (R56AG048075)

  • Justin Lessler
  • Derek A Cummings

Wellcome Trust (200861/Z/16/Z)

  • Steven Riley

National Institute of Allergy and Infectious Diseases (R01AI114703)

  • Derek A Cummings

Guangzhou Government (2019B121205009)

  • Huachen Zhu
  • Yi Guan

Guangzhou Government (HZQB-KCZYZ-2021014)

  • Huachen Zhu
  • Yi Guan

National Institutes of Health (R01TW0008246)

  • Jonathan M Read
  • Steven Riley
  • Derek A Cummings

Wellcome Trust (200187/Z/15/Z)

  • Steven Riley

Medical Research Council (MR/S004793/1)

  • Jonathan M Read

Physical Sciences Research Council (EP/N014499/1)

  • Jonathan M Read

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The following institutional review boards approved the study protocols: Johns Hopkins Bloomberg School of Public Health(IRB 1716), University of Florida (IRB201601953), University of Liverpool, University of Hong Kong (UW 09-020) and Guangzhou No. 12 Hospital ("Research on human influenza virus immunity in Southern China"). Written informed consent was obtained from all participants over 12 years old; verbal assent was obtained from participants 12 years old or younger. Written permission of a legally authorized representative was obtained for all participants under 18 years old.

Copyright

© 2022, Yang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,273
    views
  • 212
    downloads
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Bingyi Yang
  2. Bernardo García-Carreras
  3. Justin Lessler
  4. Jonathan M Read
  5. Huachen Zhu
  6. C Jessica E Metcalf
  7. James A Hay
  8. Kin O Kwok
  9. Ruiyun Shen
  10. Chao Q Jiang
  11. Yi Guan
  12. Steven Riley
  13. Derek A Cummings
(2022)
Long term intrinsic cycling in human life course antibody responses to influenza A(H3N2): an observational and modelling study
eLife 11:e81457.
https://doi.org/10.7554/eLife.81457

Share this article

https://doi.org/10.7554/eLife.81457

Further reading

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease
    Bo Zheng, Bronner P Gonçalves ... Caoyi Xue
    Research Article

    Background:

    In many settings, a large fraction of the population has both been vaccinated against and infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, quantifying the protection provided by post-infection vaccination has become critical for policy. We aimed to estimate the protective effect against SARS-CoV-2 reinfection of an additional vaccine dose after an initial Omicron variant infection.

    Methods:

    We report a retrospective, population-based cohort study performed in Shanghai, China, using electronic databases with information on SARS-CoV-2 infections and vaccination history. We compared reinfection incidence by post-infection vaccination status in individuals initially infected during the April–May 2022 Omicron variant surge in Shanghai and who had been vaccinated before that period. Cox models were fit to estimate adjusted hazard ratios (aHRs).

    Results:

    275,896 individuals were diagnosed with real-time polymerase chain reaction-confirmed SARS-CoV-2 infection in April–May 2022; 199,312/275,896 were included in analyses on the effect of a post-infection vaccine dose. Post-infection vaccination provided protection against reinfection (aHR 0.82; 95% confidence interval 0.79–0.85). For patients who had received one, two, or three vaccine doses before their first infection, hazard ratios for the post-infection vaccination effect were 0.84 (0.76–0.93), 0.87 (0.83–0.90), and 0.96 (0.74–1.23), respectively. Post-infection vaccination within 30 and 90 days before the second Omicron wave provided different degrees of protection (in aHR): 0.51 (0.44–0.58) and 0.67 (0.61–0.74), respectively. Moreover, for all vaccine types, but to different extents, a post-infection dose given to individuals who were fully vaccinated before first infection was protective.

    Conclusions:

    In previously vaccinated and infected individuals, an additional vaccine dose provided protection against Omicron variant reinfection. These observations will inform future policy decisions on COVID-19 vaccination in China and other countries.

    Funding:

    This study was funded the Key Discipline Program of Pudong New Area Health System (PWZxk2022-25), the Development and Application of Intelligent Epidemic Surveillance and AI Analysis System (21002411400), the Shanghai Public Health System Construction (GWVI-11.2-XD08), the Shanghai Health Commission Key Disciplines (GWVI-11.1-02), the Shanghai Health Commission Clinical Research Program (20214Y0020), the Shanghai Natural Science Foundation (22ZR1414600), and the Shanghai Young Health Talents Program (2022YQ076).

    1. Epidemiology and Global Health
    Marina Padilha, Victor Nahuel Keller ... Gilberto Kac
    Research Article Updated

    Background:

    The role of circulating metabolites on child development is understudied. We investigated associations between children’s serum metabolome and early childhood development (ECD).

    Methods:

    Untargeted metabolomics was performed on serum samples of 5004 children aged 6–59 months, a subset of participants from the Brazilian National Survey on Child Nutrition (ENANI-2019). ECD was assessed using the Survey of Well-being of Young Children’s milestones questionnaire. The graded response model was used to estimate developmental age. Developmental quotient (DQ) was calculated as the developmental age divided by chronological age. Partial least square regression selected metabolites with a variable importance projection ≥1. The interaction between significant metabolites and the child’s age was tested.

    Results:

    Twenty-eight top-ranked metabolites were included in linear regression models adjusted for the child’s nutritional status, diet quality, and infant age. Cresol sulfate (β=–0.07; adjusted-p <0.001), hippuric acid (β=–0.06; adjusted-p <0.001), phenylacetylglutamine (β=–0.06; adjusted-p <0.001), and trimethylamine-N-oxide (β=–0.05; adjusted-p=0.002) showed inverse associations with DQ. We observed opposite directions in the association of DQ for creatinine (for children aged –1 SD: β=–0.05; pP=0.01;+1 SD: β=0.05; p=0.02) and methylhistidine (–1 SD: β = - 0.04; p=0.04;+1 SD: β=0.04; p=0.03).

    Conclusions:

    Serum biomarkers, including dietary and microbial-derived metabolites involved in the gut-brain axis, may potentially be used to track children at risk for developmental delays.

    Funding:

    Supported by the Brazilian Ministry of Health and the Brazilian National Research Council.